Evaluation of biological treatment in pediatric patients with familial Mediterranean fever: a retrospective study of 832 patients
{{output}}
Objective: Biologic agents have been used in colchicine-resistant familial Mediterranean fever (FMF) patients and in patients with comorbidities including juvenile idiopathic arthritis (JIA). The main aim of our study was to eval... ...
